%20-%20https://sketch.com%20--%3e%3ctitle%3e3ECBBF50-FD08-412A-943D-2CFC5E025A16%3c/title%3e%3cdesc%3eCreated%20with%20sketchtool.%3c/desc%3e%3cg%20id='Stylesheet'%20stroke='none'%20stroke-width='1'%20fill='none'%20fill-rule='evenodd'%3e%3cg%20transform='translate(-926.000000,%20-668.000000)'%20id='BUTTONS'%3e%3cg%20transform='translate(100.000000,%20597.000000)'%3e%3cg%20id='BTN-/-RIGHTS'%20transform='translate(816.000000,%2065.000000)'%3e%3cg%20id='ICON-/-Rights'%20transform='translate(10.000000,%206.000000)'%3e%3cpath%20d='M13.5752841,0%20L1.34943182,0%20C0.59375,0%200,0.586666667%200,1.33333333%20L0,22.6666667%20C0,23.4133333%200.620738636,24%201.34943182,24%20L17.6505682,24%20C18.40625,24%2019,23.3866667%2019,22.6666667%20L19,5.36%20L13.5752841,0%20Z%20M13.5752841,1.89333333%20L17.0838068,5.36%20L13.5752841,5.36%20L13.5752841,1.89333333%20Z%20M1.34943182,22.6666667%20L1.34943182,1.33333333%20L12.1988636,1.33333333%20L12.1988636,5.36%20C12.1988636,6.10666667%2012.7926136,6.69333333%2013.5482955,6.69333333%20L17.6235795,6.69333333%20L17.6505682,22.6666667%20L1.34943182,22.6666667%20Z'%20id='Shape'%20fill='%23595959'%20fill-rule='nonzero'%3e%3c/path%3e%3ccircle%20id='Oval'%20stroke='%23595959'%20stroke-width='1.5'%20fill='%23595959'%20cx='9.5'%20cy='13.5355339'%20r='5.5'%3e%3c/circle%3e%3cpolyline%20id='Path-2'%20stroke='%23FFFFFF'%20stroke-width='1.5'%20transform='translate(9.500000,%2013.035534)%20rotate(45.000000)%20translate(-9.500000,%20-13.035534)%20'%20points='8%2016.0355339%2011%2016.0355339%2011%2010.0355339'%3e%3c/polyline%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
The introduction of antiretroviral (ARV) therapy has dramatically altered the morbidity profile of HIV-positive populations, with an increase in prevalence of non-communicable disease risk factors such as overweight and obesity being observed( Reference Crum-Cianflone, Roediger and Eberly 1 , Reference Tate, Willig and Willig 2 ). This is of particular concern in South Africa where, among adults over 15 years of age, 17·8 % were estimated to be living with HIV in 2008( 3 ) and approximately 45 % were found to be overweight or obese in the 2003 Demographic and Health Survey (SADHS)( 4 ).
Although the public health impact of HIV and associated non-communicable disease risk is greatest in low- to middle-income countries, to date most studies have been conducted in high-income countries, on predominantly ARV-treated males with low BMI( Reference Crum-Cianflone, Tejidor and Medina 5 – Reference Mwamburi, Wilson and Jacobson 8 ). Lipodystrophy, a commonly recognized side-effect of certain ARV drugs, has been linked to visceral fat accumulation and metabolic disorders such as dyslipidaemia and glucose intolerance( Reference Dave, Lambert and Badri 9 ). In black South African (SA) women, ARV-associated increases in BMI, fat mass, percentage body fat and waist circumference, but not in lean body mass or waist:hip ratio, have been shown( Reference Esposito, Coutsoudis and Visser 10 ). This increase in fat, as well as the proposed tendency towards visceral rather than subcutaneous fat accumulation( Reference Mercier, Gueye and Cournil 11 ), must therefore be further explored in this population due to the potential long-term negative effects on disease risk and health( Reference Despres 12 ).
While the evidence for body composition changes associated with ARV drugs continues to grow, there is less research focusing on the effect of the HIV infection itself. Hadigan et al.( Reference Hadigan, Miller and Corcoran 13 ) found that, independent of ARV, HIV-positive women in the USA demonstrated a higher percentage body fat and truncal fat and lower percentage lean body mass than HIV-negative controls. In addition, other data suggest that HIV-positive patients with higher BMI, skinfold thicknesses and insulin concentrations prior to ARV initiation may be more likely to develop lipodystrophy over 2 years of ARV drug use( Reference George, Venter and Van Deventer 14 ).
Although HIV-positive status has traditionally been associated with low energy intake, most likely as a result of reduced appetite( Reference Macallan, Noble and Baldwin 15 ), SA data show energy intake in HIV-positive individuals to be equivalent to, or in excess of, that of their HIV-negative counterparts( Reference Hattingh, Walsh and Veldman 16 ). However, high total and saturated fat intakes, as well as low n-3 PUFA and fibre intakes, have also been reported in HIV-positive populations, which may indicate overall poor diet quality( Reference Hattingh, Walsh and Veldman 16 – Reference Hendricks, Willis and Houser 19 ). This suggests that HIV patients may be as affected by the global obesity epidemic as the wider population, and that poor diet quality may be a key factor in the increasing prevalence of overweight and obesity in HIV-positive populations. The majority of these studies, however, did not include HIV-negative control groups; thereby making the impact of HIV infection itself difficult to ascertain.
In the present paper we examine dietary intake and body composition (fat and lean tissue) in ARV-naïve HIV-positive and HIV-negative black urban SA women. In addition, we explore whether the relationships between HIV infection, body composition and dietary variables are influenced by differences in disease severity by comparing affected women with low and relatively preserved CD4 counts.
Methods
Participants
The present study was a baseline dietary intake and body composition analysis of HIV-negative and HIV-positive black women participating in a longitudinal assessment of bone health in urban South Africa. The aim was to recruit ninety-five (±5) HIV-negative and seventy-three (±10) in each of the two HIV-positive groups. This sample size was based on calculations for the longitudinal study to detect a 2 % change in lumbar spine bone mineral density, allowing for a between-individual CV in bone mineral density of 5 %, with 95 % confidence and 80 % power. Inclusion criteria required women to be over 18 years of age; premenopausal; not pregnant or not planning to become pregnant for at least 12 months of the follow-up; and, if HIV positive, not yet using ARV and free from any current AIDS-related illness as defined by the WHO or the US Centers for Disease Control and Prevention. Two hundred and forty-seven women in total, HIV-positive (HIV+; n 149) and HIV-negative (HIV−; n 98), were recruited at Chris Hani Baragwanath Academic Hospital in Soweto, through contact with either the ‘ZAZI’ voluntary counselling and testing centre or the hospital's HIV clinic. Participants were divided as follows: (i) HIV-negative (group 1; HIV−, n 98); (ii) HIV-positive with preserved CD4 counts (≥350 × 106 cells/l), not eligible for ARV therapy (group 2; HIV+ non-ARV, n 74); and (iii) HIV-positive with low CD4 counts (≤200 × 106 cells/l), eligible for ARV therapy and due to start ARV (group 3; HIV+ pre-ARV, n 75).
Anthropometry
Weight was measured to the nearest 0·1 kg using a digital scale (Scales 2000, Durban, South Africa) and height was measured to the nearest 1 mm using a wall-mounted stadiometer (Holtain, Crymych, UK) and with the participant's head in the Frankfort horizontal plane. These measurements were used to calculate the BMI (weight (kg) divided by the square of height (m2)) of each participant. Underweight, normal weight, overweight and obese were defined as BMI < 18·5 kg/m2, BMI = 18·5–24·9 kg/m2, BMI = 25·0–29·9 kg/m2 and BMI ≥ 30·0 kg/m2, respectively. Waist circumference, taken approximately half-way between the iliac crest and the lowest rib, and hip circumference, taken at the maximum circumference around the hips, were measured using a non-stretchable measuring tape to the nearest 1 cm. All measurements were carried out by trained investigators using standardised procedures and participants wore minimal clothing and no shoes while measurements were taken.
Body composition
Dual energy X-ray absorptiometry (DXA) scans were performed according to standard procedures using a Hologic QDR 4500A dual-energy X-ray absorptiometer (software version 12·5:7; Hologic Inc., Bedford, MA, USA). Whole-body fat and lean mass were analysed as whole body less head (WBLH) because many of the women wore wigs and hair weaves, which could have affected the DXA measurements in the head region. These data have been published by Hamill et al.( Reference Hamill, Ward and Pettifor 20 ). Trunk and limb (arms and legs) fat masses were derived from DXA scans. Percentage fat mass for WBLH, as well as for the trunk and limbs as percentages of WBLH fat mass, were calculated. To compare body fat distribution between the groups, trunk:limb fat mass was determined. Fat mass:lean mass2 was also calculated as this was shown to best describe the relationship between fat and lean mass in this population( Reference Hamill, Ward and Pettifor 20 ).
Dietary intake
The dietary assessment tool used in the present study was an interviewer-conducted quantitative FFQ developed for use in South Africa. The questionnaire took on average 40 min to complete and included a total of 214 commonly eaten foods. These food items were derived from analyses of eleven dietary surveys conducted in rural and urban South Africa since 1983, and the list includes all foods eaten by at least 3 % of the population( Reference Nel and Steyn 21 ). The FFQ was extensively piloted on SA adolescents from the Birth to Twenty cohort at both 15 years (interviewing both adolescents and their primary caregivers, n 150( Reference Zingoni, Norris and Griffiths 22 )) and 17 years of age (n 1700 (AB Feeley, unpublished results)), as well as on adult research assistants during training, and modified accordingly.
To cater for illiteracy in the SA population, the FFQ utilises food flash cards (high-quality photographs) of the food items( Reference Steyn and Senekal 23 ). Data were collected on the previous week's (7 d) dietary intake, including convenience food products, in order to estimate habitual intake for each participant. Participants were asked to separate the food flash cards into a series of piles. First, they went through each food card and created a pile of food items they ‘rarely/never’ eat or drink. Thereafter, they went through the remaining food cards and created a pile of food items they eat/drink less frequently (‘occasional’), and a pile they eat regularly and in the past 7 d. The participant was then prompted for information on the frequency and amounts of the food items consumed regularly in her diet, the details of which were recorded on the FFQ. Portion sizes were estimated using household measures and a combination of two-dimensional life-size drawings of foods and utensils and three-dimensional food models as described and validated by Steyn et al.( Reference Steyn, Senekal and Norris 24 ). Items eaten occasionally or rarely/never were also recorded.
Coding involved the conversion of the household measures (e.g. one cup/one serving spoon/one slice) to grams so that an average intake over the previous 7 d could be calculated. Nutrient composition (energy and macronutrients) was estimated using FoodFinder3, a nutrient analysis software program based on the SA Medical Research Council food composition tables( Reference Langenhoven, Kruger and Gouws 25 ).
Quality control for dietary data acquisition was undertaken by extensive and repeated training of interviewers, reviewing the questionnaires for missing or spurious data, questioning participants on ambiguous answers and spot-checking questionnaires by a second interviewer (usually the senior nutritionist). The plausibility of the reported energy intake data was assessed according to study-specific cut-offs as described by Goldberg et al.( Reference Goldberg, Black and Jebb 26 ) and Black( Reference Black 27 ).
The US Dietary Reference Intakes( 28 ) for energy and macronutrients were selected for assessing the intakes of the study groups compared with recommendations, as these are most commonly used in South Africa and the most useful for comparison with other published data. Nutrient intakes were therefore compared with the Estimated Energy Requirement, the RDA for protein and carbohydrate and the Adequate Intake for fibre in adult women aged 19–50 years. The median intakes for carbohydrate, protein and fat as proportions of total energy intake were calculated and compared with the Acceptable Macronutrient Distribution Ranges.
Variation in the food items consumed between study groups was assessed by comparing the twenty most commonly consumed items, as well as their respective food groups. The top twenty reported food items were ranked from the most to the least consumed according to the mean intake reported in grams per day.
Socio-economic status and education
Socio-economic status (SES) was assessed using an asset index similar to that used by McVeigh et al.( Reference McVeigh, Norris and de Wet 29 ). This scored each participant according to the number of household assets she possessed out of a possible twelve (electricity, television, radio, motor vehicle, fridge, washing machine, telephone, video machine, microwave, MNET television channel, DSTV satellite television, cellular telephone). An asset score percentage was then calculated for each participant ((number of recorded household assets/12) × 100).
Level of education was assessed according to the number of years completed at primary, secondary or tertiary level.
Ethics
The study was approved by the University of the Witwatersrand Human Research Ethics Committee (HREC Number: M101525) and the Gauteng Department of Health. Individuals gave written consent prior to enrolment into the study.
Statistical analysis
Data were analysed using the statistical software package STATA 11·0. Where ‘inaccurate reporters’ were identified, dietary data were truncated using Goldberg cut-offs so that energy and macronutrient intakes represented the lowest or highest plausible intake for under- or over-reporters, respectively, according to body size. Continuous variables for participant characteristics, as well as anthropometric and body composition measurements and dietary intake, were not normally distributed and were therefore summarised using the median and interquartile range. Education level and BMI categories were summarised as percentage in each group. Continuous and categorical variables for participant characteristics were compared between the three study groups using the Kruskal–Wallis test for non-parametric data and the χ 2 test, respectively. Age was found to be significantly different between groups; therefore all subsequent analyses were adjusted for age. Regression analyses were performed to compare differences in anthropometric and body composition variables between the HIV− group and the HIV+ non-ARV and HIV+ pre-ARV groups combined. Between-group comparisons were then made using multiple linear regression models with dummy variables created to distinguish between the HIV+ groups. These methods were repeated for analysis of dietary intake data; however, in addition to age-adjusted analyses, subsequent regression analyses were controlled for both age and total energy intake in order to adjust for the dietary variation attributed to differences in body size between groups. Finally, multiple regression models were used to explore whether any of the variables found to differ between groups were independent predictors of anthropometric and body composition differences. Where appropriate, hypotheses were conducted using Bonferonni-adjusted α levels of 0·016 per test (0·05/3).
Results
Table 1 summarises the participant characteristics and anthropometric variables for the three study groups (previously described, in part, by Hamill et al.( Reference Hamill, Ward and Pettifor 20 )). The HIV+ pre-ARV group had a significantly lower median CD4 count (175 × 106 cells/l) than the HIV+ non-ARV group (420 × 106 cells/l) as a result of the study design (P < 0·001). Both SES score and level of education were similar across all groups. The HIV+ pre-ARV group had significantly lower body weight, BMI and waist and hip circumference than the other groups (most P < 0·001). The prevalence of overweight and obesity was high in the whole sample, with 59 % of women being overweight or obese. There was a significant difference in the distribution of participants across BMI categories between the groups, with the HIV+ pre-ARV group having significantly fewer obese individuals (16 %) than both the HIV− (30 %; P = 0·01) and HIV+ non-ARV (37 %; P = 0·01) groups. The HIV+ pre-ARV group also had a higher underweight prevalence (11 %; P < 0·01), approximately three- and eleven-fold higher than the HIV− and HIV+ non-ARV groups, respectively.
Participant characteristics and anthropometric variables according to study group: premenopausal black women, Soweto, Johannesburg, South Africa
ARV, antiretroviral; IQR, interquartile range; SES, socio-economic status; ND, not determined; NA, not applicable.
Data are presented as median and interquartile range unless otherwise indicated.
*Multiple regression analysis adjusted for age, P < 0·05 indicates significance.
†Kruskal–Wallis test, P < 0·05 indicates significance.
‡χ 2 test, P < 0·05 indicates significance.
There was a significant difference in fat mass between the groups, with the HIV+ pre-ARV group having lower total (P < 0·001), trunk (P < 0·001) and limb fat masses (P < 0·001), and percentage body fat (P < 0·001), than the other two groups (Table 2). However, when expressed as a percentage of whole-body fat mass, trunk and limb fat percentages were no longer different between the groups. The HIV+ pre-ARV group had lower fat mass:lean mass2 than the other two groups; however, trunk:limb fat mass was not different between the groups. Correlations confirmed the relationship between CD4 count and fat mass (r = 0·273; P = 0·019) and CD4 count and lean mass (r = 0·299; P = 0·05).
Body composition variables according to study group: premenopausal black women, Soweto, Johannesburg, South Africa
DXA, dual energy X-ray absorptiometry; ARV, antiretroviral; IQR, interquartile range, WBLH, whole body less head.
*Multiple regression analysis adjusted for age, P < 0·05 indicates significance.
†Non-significant due to Bonferroni adjustment.
Table 3 presents the results of multiple regression analyses for BMI, WBLH fat mass and lean mass, trunk fat mass and limb fat mass. Only the variables which contributed significantly to the models are presented. The overall models explain 14 % of the variance in both BMI and WBLH fat mass, 34 % of the variance in WBLH lean mass and 13 % of the variance in both trunk and limb fat masses. Age and being in the HIV+ pre-ARV group significantly contributed to the models for BMI, WBLH fat mass and trunk fat mass (all P < 0·001), with HIV+ pre-ARV group status being associated with an approximately 4·5 kg/m2 decrease in BMI, an 8 kg decrease in WBLH fat mass and a 3·5 kg decrease in trunk fat mass. Age, height and being in the HIV+ pre-ARV group were significant contributors to the variation in both WBLH lean mass (all P < 0·001) and limb fat mass (P = 0·004, P = 0·042 and P < 0·001, respectively), with an approximately 3 kg lower lean mass and 4 kg lower limb fat mass being associated with HIV+ pre-ARV group status.
Multiple regression analyses for BMI, WBLH fat mass, WBLH lean mass, trunk fat mass and limb fat mass: premenopausal black women, Soweto, Johannesburg, South Africa
WBLH, whole body less head; ref., reference category; ARV, antiretroviral.
All variables included in the above models were those which showed significance in prior analyses, P < 0·05.
The daily energy and macronutrient intakes are presented in Table 4. None of the components of dietary intake were different between HIV− and HIV+ participants, with the exception of total protein and animal protein intakes which were significantly lower in the HIV− than the HIV+ individuals (P = 0·023 and P = 0·015, respectively). However, when adjusted for total energy intake, the differences in total and animal protein intake were no longer significant. Between-group analyses similarly found no differences between HIV−, HIV+ non-ARV and HIV+ pre-ARV groups in any of the dietary intake variables. Dietary intake exceeded the Estimated Energy Requirement, the RDA for carbohydrate and protein, as well as the Adequate Intake for fibre across all three study groups.
Daily energy and macronutrient intakes according to study group and comparison with dietary recommendations: premenopausal black women, Soweto, Johannesburg, South Africa
ARV, antiretroviral; IQR, interquartile range.
*Multiple regression analysis adjusted for age, P < 0·05 indicates significance.
†Multiple regression analysis adjusted for age and total energy intake (kJ), P < 0·05 indicates significance.
‡Estimated Energy Requirement for adult woman aged 19–50 years.
§RDA for adult woman aged 19–50 years.
||Adequate Intake for adult woman aged 19–50 years.
Carbohydrate, protein, fat and fibre accounted for approximately 54 %, 11 %, 30 % and 4 %, respectively, of total energy intake across all three groups (data not shown). Intakes, as percentages of total energy intake, were therefore within the Acceptable Macronutrient Distribution Ranges for carbohydrate (45–65 %), protein (10–35 %) and fat (20–35 %) for all groups. Approximately 8 %, 5 % and 21 % of participants in the sample had carbohydrate, fat and protein intakes, respectively, below the acceptable range, while 5 % and 19 % had carbohydrate and fat intakes, respectively, above the acceptable range. Alcohol accounted for less than 1 % of total energy intake in all groups.
The twenty most commonly consumed food items and their respective food groups are shown in Table 5. Data are presented for the whole sample due to the lack of differences seen in the food items consumed between study groups. The HIV+ pre-ARV group consumed the highest amount of food mass from the top twenty items (1176 g/d) compared with the HIV− and HIV+ non-ARV groups (929 and 1142 g/d, respectively). The most commonly consumed food item was maize meal (made into a stiff porridge/‘pap’) at a mean intake of 258 g/d. The most commonly recorded food group was cereal and cereal products (featured four times in the top twenty), with most cereal products being highly refined ‘white carbohydrate’. Fruit and vegetables both featured twice; however, the vegetable component included French fries which are high in fat (usually sunflower oil). Sugar consumption was high overall, with granulated white sugar being the most frequently recorded food item in the sample (reported 533 times at an average of 15 g/d) and sweetened carbonated drinks being ranked second with a mean consumption of 197 g/d and equating to approximately 340 kJ of energy daily. Meat and meat products featured three times in the top twenty food items; however, the cuts of meat tended to be highly processed and fried in sunflower oil (e.g. polony and battered fried chicken). In addition, fish did not feature in the top twenty food items. Use of fats and oils was very common, with brick/hard margarine and sunflower oil being the regularly reported products (13 g/d and 6 g/d, respectively). Condiments, high in fat and/or sugar, were regularly added to meals and snacks, with both atchar (a spicy condiment of mangoes and honey, 19 g/d) and tomato sauce (10 g/d) featuring in the top twenty food items consumed.
Top twenty food items consumed in the sample of premenopausal black women, Soweto, Johannesburg, South Africa
*Food items grouped according to the current South African Medical Research Council food composition tables( Reference Wolmarans, Danster and Dalton 37 ).
Discussion
In this sample of black, urban, SA women, HIV-positive individuals had lower weight and BMI, as well as lower fat and lean masses and percentage body fat, than their HIV-negative counterparts. This was primarily as a result of the HIV-positive individuals with low CD4 counts having low measures. Multiple regression analyses showed that HIV+ pre-ARV status, but not HIV+ non-ARV status, was a key contributor to differences in WBLH fat mass and WBLH lean mass, as well as both trunk and limb fat masses; associated with 8 kg and 3 kg less fat and lean mass, respectively, as well as 3·5 kg less trunk fat and 4 kg less limb fat. This challenges the stereotypical view of HIV as a disease associated with involuntary weight loss and wasting prior to ARV initiation and suggests that weight loss may only become a symptom in this population at more severe disease states.
Although WBLH fat mass, as well as trunk and limb fat masses, were lower in the HIV+ pre-ARV group than the other study groups, there were no differences in relative terms (trunk and limb fat percentages) across all groups. This, together with the similarity found in trunk:limb fat mass between study groups, suggests lower body fat across all sites rather than an altered fat distribution with advanced HIV infection. This contradicts previous US data which showed an increase in both percentage trunk fat and trunk:limb fat and a decrease in peripheral fat independent of ARV treatment in HIV-positive women compared with HIV-negative controls( Reference Hadigan, Miller and Corcoran 13 ). In addition, it suggests a different pattern of fat loss than that associated with ARV treatment, where lipodystrophy is characterised by abdominal fat accumulation and subcutaneous fat loss, predominantly at the face, limbs and buttocks( Reference James, Carruthers and Carruthers 30 ). This is speculative, however, and a longitudinal study is currently being undertaken in this population which it is hoped will provide more definitive answers.
As previously documented by Hamill et al.( Reference Hamill, Ward and Pettifor 20 ), the HIV+ pre-ARV group had a lower fat mass:lean mass2 than the other two study groups, demonstrating approximately 21 % and 16 % less fat for each kilogram of lean mass than the HIV− and HIV+ non-ARV groups, respectively. This provides evidence of lower fat mass, rather than lean tissue, at more advanced stages of HIV infection. Although previous literature has found HIV to be associated with preferential loss of lean compared with fat tissue, particularly in male subjects, a disproportionately higher loss of fat mass has been shown in US women( Reference Grinspoon, Corcoran and Miller 31 ). In addition, a preferential loss of fat rather than lean tissue mass has been demonstrated in males with high body fat percentages at baseline, compared with those having less than 15 % body fat( Reference Mulligan, Tai and Schambelan 32 ).
Overweight and obesity were common in the sample overall, with a combined prevalence of 59 %, a prevalence higher than the national estimate of 55 % reported for black women in the 2003 SADHS( 4 ). Although the distribution of women across BMI cut-offs differed significantly between the HIV+ pre-ARV group and the other two study groups, there was still a 44 % prevalence of overweight and obesity in this group, while another 11 % were classified as underweight. Even at more advanced stages of HIV infection, women are affected by obesity and this needs to be addressed in the population as a whole.
There were no reported differences in dietary intake across study groups, with the exception of total and animal protein intakes which were lower in the HIV− group than in the HIV+ groups combined. However, when adjusted for age and total energy intake, these differences were no longer significant. There was no relationship between protein intake and SES (P = 0·202). These results also highlight that all groups, including the pre-ARV therapy group with lower median BMI, consume an obesogenic diet. Given the high levels of inflammation and high carbohydrate intake, these participants are likely to have a high prevalence of insulin resistance and other metabolic abnormalities. These are areas for potential future research.
Food item and food group analyses showed similar consistency of consumption across the groups, regardless of HIV status. The main contributor to the variation in food mass consumed between the three groups seemed to be ‘pap’ (maize meal porridge), which differed by approximately 135 g/d between the HIV+ pre-ARV group and the HIV– group and approximately 92 g/d between the HIV+ pre-ARV group and the HIV+ non-ARV group. Diets in the sample as a whole were very high in refined carbohydrate, which is reflected by the high total digestible carbohydrate intake (approximately three-fold higher than the RDA of 130 g/d). Consumption of processed and fast-food products was common and that of fruits and vegetables rare, with the vegetable items consumed (e.g. tomato and onion stew) usually containing added sugar and/or fat. In addition to added sugar intakes, high sugar-based products were also common; with carbonated soft drinks featuring second in the top twenty food items consumed. This is a concern due to the link seen between sugar-sweetened beverage intake and weight gain, as well as diabetes and CVD risk( Reference Hu and Malik 33 , Reference Malik, Popkin and Bray 34 ). The lack of fish, and therefore n-3 PUFA, in the top twenty reported food items should also be addressed due to the important role that these essential fatty acids have in regulating immune function( Reference Calder and Yaqoob 35 ). The highly processed nature of food products, as well as high sugar and fat and low vegetable consumption in the sample is an important health issue and highlights the urgent need to address obesity and its risk factors throughout the population.
Although providing an overall picture of habitual energy and macronutrient intakes, as well as of commonly consumed food items, the dietary data had certain limitations. The proportion of women classified as ‘under-reporters’ was very high (31 %, data not shown), suggesting that a substantial number were underestimating their consumption. This may have been due to the high prevalence of overweight and obesity in the sample, as high BMI has previously been shown to predict under-reporting( Reference Price, Paul and Cole 36 ). Due to the negative impact that excluding these participants would have had on sample size, truncation was therefore chosen as the best possible method of minimising the effects of under-reporting on study results. Classification of food items based on the SA food composition table was also flawed as it misclassified items such as French fries into the vegetable group, thereby overestimating vegetable consumption in the sample. This classification should be revised in the future to ensure that vegetables high in starch with added fat are more accurately categorised.
A key limitation of the study was that the participants were not a random sample of the adult female population of Soweto and the surrounding area, as inclusion in the study required the women to present at the Chris Hani Baragwanath Hospital's Perinatal HIV Research Unit, HIV clinic, or voluntary counselling and testing centre. Women must, therefore, both know that the services exist and have access to them, must be healthy enough to present at the hospital, and must have sufficient information on HIV and its risks to be motivated to seek counselling or care. This could mean that the HIV-positive and HIV-negative participants included in the study are not a truly representative sample and may also have better knowledge of poor dietary practices and other health risks than the wider population.
Regardless of these weaknesses, the present paper provides unique data on diet and body composition differences between HIV-negative and HIV-positive women at varying levels of immunosuppression prior to treatment. In addition, the longitudinal design of the broader study will allow for future analysis of the changes in anthropometric, body composition and dietary variables in this population at 6 months, 12 months and 24 months follow-up.
Conclusion
Our data show that immunosuppression may be a predictor of anthropometric and body composition changes in HIV-positive women and that, in populations with high obesity prevalence, these differences become evident only at advanced stages of infection. This highlights the need for a change in the way diet and body composition are viewed in HIV-positive patients, while emphasising that poor dietary habits should be addressed in the SA female, urban population as a whole.
Acknowledgements
Sources of funding: This work was supported by the UK Medical Research Council (programme grant number U105960371) and by an MRC PhD Clinical Research Training Fellowship (MC_EX_G1001958 to M.M.H.). Conflicts of interest: All authors report no conflicts of interest. Authors’ contributions: The study was designed by M.M.H. and A.P. and the study design was reviewed by M.M.H., J.M.P., S.A.N. and A.P. S.V.W. and A.B.F. analysed the data. The initial phase of data analysis was conducted as part of S.V.W.'s MSc research project at the London School of Hygiene and Tropical Medicine. All authors contributed to interpretation and the writing of the manuscript. All authors had full access to the data. S.A.N. had responsibility for the final decision to submit the manuscript for publication. Acknowledgements: The authors wish to acknowledge all of the study participants and staff at the Developmental Pathways for Health Research Unit, ZAZI/Perinatal HIV Research Unit, Nthabiseng and Lilian Ngoyi clinics, Johannesburg, South Africa.
